By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) 

25 Science Park, Room 561

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-5606 Fax: 203-624-5627


SEARCH JOBS



Segment
Drug Discovery





Company News
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens 9/8/2014 2:44:44 PM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrate Delafloxacin's Potent And Rapid Antimicrobial Activity Against Neisseria Gonorrhoeae 9/8/2014 10:10:59 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Reports On PK Profile Of A Single Oral Dose Of Delafloxacin In Support Of U.S. Phase 3 Gonorrhea Program 9/8/2014 7:40:59 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity Against Complicated Urinary Tract Infection Pathogens 9/8/2014 7:39:38 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Highlighting Delafloxacin And ESKAPE Candidates In Twelve Presentations At 2014 ICAAC Meeting 9/4/2014 10:19:35 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Bolsters Board Of Directors With Appointment Of Christopher Kiritsy 8/15/2014 7:45:00 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Reports Top-Line Results Showing Equivalent Exposures After Oral and Intravenous Delafloxacin Administration 8/11/2014 10:55:15 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Announces Accepted Abstracts At The 2014 Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 7/24/2014 10:03:57 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Phase 3 Study Of I.V. And Oral Delafloxacin Has Begun Enrolling Patients With Acute Bacterial Skin And Skin Structure Infections 5/5/2014 12:27:16 PM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) To Present At Needham & Company's Annual Healthcare Conference 4/3/2014 1:56:25 PM
12345678
//-->